Osaic Holdings
ACET icon

Osaic Holdings’s Adicet Bio ACET Stock Holding History

Osaic Holdings’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$7 – 7820
2025
Q3 		$7 Buy
+1
New +$12 ﹤0.01% 7868
2024
Q2 		– Sell
-103
Closed -$3.88K – 7388
2024
Q1 		$3.88K Hold
103
– – ﹤0.01% 6206
2023
Q4 		$3.12K Hold
103
– – ﹤0.01% 6368
2023
Q3 		$2.26K Hold
103
– – ﹤0.01% 6588
2023
Q2 		$4.01K Hold
103
– – ﹤0.01% 6408
2023
Q1 		$9.5K Sell
103
-2
-2% -$251 ﹤0.01% 6008
2022
Q4 		$14.8K Buy
105
+103
+5,150% +$25.7K ﹤0.01% 5756
2022
Q3 		$0 Buy
2
+1
+100% +$254 ﹤0.01% 7221
2022
Q2 		$0 Hold
1
– – ﹤0.01% 7294
2022
Q1 		$0 Hold
1
– – ﹤0.01% 7195
2021
Q4 		$0 Hold
1
– – ﹤0.01% 7344
2021
Q3 		$0 Hold
1
– – ﹤0.01% 7153
2021
Q2 		$0 Hold
1
– – ﹤0.01% 6965
2021
Q1 		$0 Hold
1
– – ﹤0.01% 6776
2020
Q4 		$0 Hold
1
– – ﹤0.01% 6368
2020
Q3 		$0 Sell
1
-1
-50% -$253 ﹤0.01% 6174
2020
Q2 		$0 Buy
2
+1
+100% +$196 ﹤0.01% 6075
2020
Q1 		$0 Buy
+1
New +$148 ﹤0.01% 6030

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Osaic Holdings's ACET Position: Q4 2025 in Review

Osaic Holdings sold out of Adicet Bio (ACET) in Q4 2025, closing a stake of 1 share — an estimated $7 sold.

Osaic Holdings first reported a position in ACET in Q1 2020 and held it in 18 quarters. The position peaked at $14.8K in Q4 2022. 49 funds tracked by Wall St. Rank hold ACET as of Q4 2025.

  • Osaic Holdings reported no remaining Adicet Bio position as of Q4 2025 after selling out during the quarter.
  • Osaic Holdings sold 1 Adicet Bio share in Q4 2025, an estimated $7.
  • Osaic Holdings first reported a position in Adicet Bio in Q1 2020 and held it in 18 quarters.
  • Osaic Holdings's Adicet Bio position peaked at $14.8K in Q4 2022.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2025.

Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.